MENU
CORT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Corcept Therapeutics (CORT) Earnings Date & Reports

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol... Show more

A.I. Advisor
published Earnings

CORT is expected to report earnings to rise 122.06% to 37 cents per share on July 30

Corcept Therapeutics CORT Stock Earnings Reports
Q2'25
Est.
$0.38
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.12
Q3'24
Beat
by $0.13
Q2'24
Beat
by $0.09
The last earnings report on May 05 showed earnings per share of 17 cents, beating the estimate of 15 cents. With 972.00K shares outstanding, the current market capitalization sits at 7.38B.
View a ticker or compare two or three
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a maker of drugs for the treatment of severe psychiatric and neurological diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com